Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters

Clostridium difficile-associated colitis is an increasing cause of morbidity and mortality in hospitalized patients, with high relapse rates following conventional therapy. We sought to determine the efficacy of rifaximin, a novel nonabsorbed antibiotic, in the hamster model of C. difficile-associat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kokkotou, Efi, Moss, Alan C., Michos, Athanasios, Espinoza, Daniel, Cloud, Jeffrey W., Mustafa, Nasima, O'Brien, Michael, Pothoulakis, Charalabos, Kelly, Ciarán P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2258528/
https://ncbi.nlm.nih.gov/pubmed/18195066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01143-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados